Compliance Documentation

Validation Documentation

Regulatory lineage, system validation, and precedent documentation for compliance review.

Regulatory Classification

EPA Registration

Hydrogen peroxide is registered with the U.S. Environmental Protection Agency as a sterilant and high-level disinfectant. Reactive Oxygen® (rO), the proprietary reagent used in TheBOX® system, is hydrogen peroxide-based. EPA registration establishes approved use conditions, concentration parameters, and application contexts for antimicrobial efficacy claims.

FDA Device Context

Vaporized hydrogen peroxide sterilization systems are cleared by the U.S. Food and Drug Administration for use in medical device reprocessing and pharmaceutical manufacturing environments. FDA clearance pathways include 510(k) premarket notification for sterilization equipment. Reactive Oxygen® has been reviewed, audited, and accepted by FDA for human tissue sterilization applications. TheBOX® system documentation, validation protocols, and process controls are structured to align with FDA inspection expectations as federal oversight extends into cannabis manufacturing sectors.

Technology Class Recognition

VHP sterilization is recognized as an established low-temperature sterilization methodology by regulatory bodies including FDA, EPA, and international equivalents. The technology class is governed by ISO standards for sterilization validation and process control.

Technology Lineage

Regulated Industry Adoption

—Medical device sterilization
—Pharmaceutical cleanroom decontamination
—Human tissue processing (allograft)
—Hospital and surgical suite decontamination
—Isolator and barrier system sterilization

Governing Standards

—ISO 14937: Sterilization of health care products
—ISO 22441: Sterilization — Low temperature vaporized hydrogen peroxide
—AAMI TIR17: Compatibility of materials subject to sterilization

Standards govern validation methodology, not cannabis-specific application.

Company Origin

PuroGen, the parent company, developed VHP sterilization systems for human tissue processing in the transplant industry. In that context, the condition of success was non-reduction of osteoinductive and osteoconductive properties—the biological characteristics that enable tissue grafts to promote bone formation and healing. The Reactive Oxygen® process demonstrated that sterilization-level microbial reduction could be achieved without compromising these sensitive biological properties. This became the governing principle when the technology was adapted for cannabis beginning in 2015: the same rigorous bar was applied to cannabinoid and terpene preservation, physical appearance of bud and flower structure, and moisture equilibrium. The standard was set at zero measurable negative effects on material integrity—a requirement inherited directly from human tissue sterilization.

Testing Constraints

Regulatory Testing Limitations

In healthcare and pharmaceutical sectors, third-party testing laboratories routinely accept a wide variety of materials for microbiological validation studies. Federal restrictions on THC-containing materials create a fundamentally different landscape for cannabis. Most accredited microbiology institutions are not licensed to receive, handle, or process Schedule I controlled substances, limiting conventional third-party validation pathways for cannabis-specific efficacy testing.

This structural constraint applies industry-wide and is not unique to any single manufacturer, technology, or system. As a result, rigorous internal testing standards and methodology become essential for demonstrating process performance in cannabis applications.

PuroGen's origin in human tissue sterilization—where internal validation discipline was foundational to regulatory acceptance—established the documentation rigor, testing methodology, and quality systems now applied to cannabis. This background positions PuroGen to meet the evidentiary expectations that will accompany federal oversight as the cannabis industry matures.

System Validation Scope

Sterilization Capabilities and Internal Performance Testing

Biological indicator validation and internal field testing under controlled cannabis processing conditions

TheBOX system is validated through controlled internal testing designed to establish baseline sterilization capability independent of cannabis material variability. These validations define system performance limits and governing process behavior for cannabis flower purification.

—Validation type: Internal controlled testing
—Scope: Baseline sterilization capability, exposure delivery behavior, and verification controls
—Independence: Cannabis material-independent system performance characterization

Validation Methods and Instrumentation

Internal testing used standardized microbial enumeration tools and controlled incubation to produce repeatable, reviewable CFU outcomes:

– 3M™ Petrifilm™ plating systems for microbial enumeration (CFU-based quantification)
– Controlled incubation using a laboratory incubator with defined temperature range and stated uniformity performance (Revolutionary Science RS-IF-203 Incufridge)
– Digital plate reading and data capture using 3M™ Petrifilm™ Plate Reader Advanced with software-based enumeration support, with results reviewed/confirmed by trained personnel
– Run documentation maintained under internal documentation control (cycle identifiers, sample IDs, incubation records, count records, and interpretation notes)

Biological Indicator / Baseline Capability Validation

Sterilization capability was established under controlled conditions to isolate inherent system performance from cannabis flower diffusion effects.

– Industry-standard indicator methodology used to verify sterilization efficacy
– Empty-chamber testing performed to isolate system performance from cannabis flower composition and porosity
– Demonstrated reductions of approximately 6-log (~1,000,000 CFU) per cycle under controlled conditions
– Establishes inherent system capability and governing process behavior independent of cannabis load composition

This testing confirms the system's sterilization potential independent of cannabis material variability.

Run-Level Vapor / Oxidant Verification (Per-Cycle Confirmation)

In addition to capability validation testing, each and every cannabis production run includes an in-cycle verification step using RO (Reactive Oxidant) verification strips.

– RO indicator strips provide immediate operator-visible confirmation that vapor-phase oxidant generation occurred during the cycle
– Indicator response is threshold-dependent (requires reactive oxidant exposure), providing confirmation of actual oxidant presence, not inferred execution
– This creates run-specific physical evidence that the cycle achieved validated oxidant conditions

This verification layer ensures sterilization execution is confirmed at the point of operation, every cycle, not assumed based on settings or cycle completion alone.

Internal Field Testing (Cannabis Operational Conditions)

After baseline capability was established, internal field testing was performed in licensed cannabis operational environments to observe performance under real processing conditions:

– Internal microbial plating conducted within licensed cannabis operational environments
– Observed reductions ranging from approximately 450,000 to 1,000,000 CFU on cannabis flower
– Results verified through customer third-party, state-certified cannabis laboratory testing where applicable
– Outcomes reflect cannabis material-dependent behavior under real processing conditions

Testing data is proprietary and subject to confidentiality agreements.

Capability vs. Observed Outcomes

System capability is constant
Process parameters, chamber conditions, and exposure profiles are governed, repeatable, and consistent across cycles and units.

Observed outcomes are cannabis material-dependent
Variability in microbial reduction reflects differences in cannabis flower density, porosity, and internal structure. Diffusion-dependent behavior within heterogeneous botanical material governs realized outcomes, not changes in system performance.

Validation protocols, biological indicator records, and cannabis field testing data are maintained under documentation control and are available for compliance review subject to confidentiality agreements.

Vapor-Phase Reactive Oxygen (rO) Generation & Verification

Run-level chemical indicator verification of oxidant presence and distribution

Each TheBOX cycle incorporates run-level vapor verification through the use of rO (Reactive Oxidant) chemical indicator strips deployed within the controlled process environment for every individual run.

These indicators are specifically responsive to vapor-phase oxidizing species generated during the sterilization cycle. Their activation requires sufficient oxidant concentration, exposure duration, and vapor diffusion—confirming that the system achieved the validated oxidative conditions required for microbial inactivation.

The indicator response is driven by direct chemical interaction with reactive oxidant species, not by secondary variables such as temperature, pressure, or cycle completion status. This ensures verification of actual oxidant presence, not inferred process behavior.

—Verification method: Chemical indicator strips (rO-responsive)
—Deployment: Every individual run within the process chamber
—Response mechanism: Direct chemical interaction with vapor-phase oxidant species
—Evidence type: Irreversible colorimetric transformation

Vapor-Phase Confirmation

Validates that oxidizing agents were successfully vaporized, distributed, and maintained within the chamber environment.

Threshold-Dependent Response

Indicator activation occurs only when oxidant concentration and exposure parameters exceed defined reactive thresholds.

Irreversible Chemical Transformation

Permanent colorimetric change confirms oxidant exposure and prevents post-cycle ambiguity or reinterpretation.

Run-Specific Physical Evidence

Each cycle produces tangible proof that reactive oxidant generation occurred as designed.

By requiring vapor-phase oxidant verification on every run, TheBOX enforces validation at the point of execution—ensuring that sterilization is not presumed, estimated, or averaged, but chemically confirmed each cycle.

Safety Documentation

Reactive Oxygen® Safety Data Sheet (SDS) — Reference Documentation

Manufacturer safety, handling, and hazard classification documentation for the process reagent

This documentation provides formal safety, handling, storage, and hazard classification information for the process reagent used within the system under controlled conditions.

Hydrogen peroxide 35% is classified as an oxidizing liquid with acute toxicity (oral and inhalation), skin and eye corrosive/irritant properties, and respiratory irritant potential. This classification applies to the concentrated reagent in isolation and is governed by standard OSHA Hazard Communication requirements.

The SDS specifies use in well-ventilated environments, storage in vented containers away from combustibles, avoidance of contamination and incompatible materials, and use of appropriate PPE during handling of the concentrated reagent. Standardized first-aid, spill response, and fire-fighting measures applicable to industrial hydrogen peroxide handling are outlined.

—Document type: Manufacturer Safety Data Sheet (SDS)
—Substance: Hydrogen Peroxide 35% (Reactive Oxygen®)
—Distributor: PuroGen Botanics LLC
—OSHA PEL: 1.0 ppm (8-hour TWA)
—ACGIH TLV: 1.0 ppm (8-hour TWA)
—Regulatory frameworks: OSHA Hazard Communication, WHMIS, DOT (UN 2014), applicable environmental reporting

Important Context

This documentation applies to the concentrated reagent prior to controlled system use. It does not represent in-process exposure, environmental release, or operational conditions, which are addressed separately through environmental monitoring and system validation studies.

Role in System Documentation

This SDS is included to demonstrate formal reagent traceability and safety documentation completeness. It supports internal safety governance and regulatory alignment but does not function as a performance, efficacy, or exposure claim.

Full Safety Data Sheets and process safety documentation are maintained under documentation control and are available through appropriate compliance channels.

Extended Safety Data Sheet (SDS) — System-Controlled Use Context

Supplementary context for reagent deployment within a closed, validated process environment

The referenced Safety Data Sheet (SDS) documents the hazard classification, handling, storage, and emergency response requirements for hydrogen peroxide 35% as a concentrated chemical reagent.

The information below provides system-specific context for how this reagent is used within a closed, validated process environment.

—Context type: System-controlled use supplementary documentation
—Reference document: Reactive Oxygen® Safety Data Sheet (SDS)
—Scope: In-process deployment conditions within TheBOX® system

System-Controlled Deployment

Within TheBOX®, Reactive Oxygen® (35% hydrogen peroxide) is:
– Metered in controlled quantities
– Vaporized inside a sealed vacuum chamber
– Maintained under defined pressure, time, and concentration parameters
– Catalytically decomposed at cycle completion into oxygen and water

At no point during normal operation is the concentrated reagent accessible to operators or released into the ambient environment.

Exposure Context

Independent environmental monitoring has demonstrated hydrogen peroxide vapor levels during operation in the range of 0.04–0.06 ppm, substantially below OSHA's 1.0 ppm 8-hour time-weighted average exposure limit.

Toxicological Context

When evaluated under ISO 10993-11 acute systemic toxicity protocols, the Reactive Oxygen® sterilant met all acceptance criteria, with no observed systemic toxicity effects.

Residue & Decomposition Context

Hydrogen peroxide decomposes into oxygen and water following cycle completion, leaving no persistent chemical residues on processed material.

Important Clarification

The SDS hazard classifications apply to the concentrated reagent prior to system use.

They do not represent in-process exposure, operator contact conditions, or environmental release during normal operation of TheBOX®, which are governed by validated engineering controls and documented separately.

Documentation Boundary

This contextual information supplements — but does not modify — the manufacturer-issued Safety Data Sheet. The SDS remains the authoritative source for chemical hazard classification and emergency response guidance.

This contextual documentation is provided for informational purposes and does not alter, replace, or supersede any manufacturer-issued safety documentation. The referenced SDS remains authoritative for all hazard classification and emergency response requirements.

Declared Validations

Reactive Oxygen® Safety — ISO 10993-11 Acute Systemic Toxicity Evaluation

GLP-compliant systemic injection testing conducted by WuXi AppTec

Acute systemic injection toxicity testing was conducted under FDA Good Laboratory Practice (21 CFR Part 58) in accordance with ISO 10993-11 and ISO 10993-12.

The evaluation assessed systemic toxicological response following single-dose exposure via intravenous and intraperitoneal administration in murine models.

No test article–associated mortality, significant clinical toxicity, or adverse body weight loss relative to vehicle controls was observed under predefined ISO pass/fail criteria.

—Test standard: ISO 10993-11:2006 (Systemic Toxicity)
—Sample preparation: ISO 10993-12:2012
—Compliance: FDA GLP (21 CFR Part 58)
—Performing laboratory: WuXi AppTec, Inc. (AAALAC accredited)
—Test system: Swiss albino mice (Mus musculus)
—Exposure routes: Intravenous and intraperitoneal
—Observation period: 72 hours post-injection
—Endpoints assessed: Mortality, clinical signs, body weight change
—Evaluation criteria: ISO-defined pass/fail thresholds

Operational Implication

For cannabis operations, this evaluation establishes that materials exposed to the process do not introduce acute systemic toxicity risk via extractable or residual compounds under defined exposure conditions.

This bounds operator exposure, downstream handling, and material-contact risk within recognized toxicological safety thresholds.

Regulatory Implication

Today (state-regulated cannabis): This validation demonstrates that the process has already been evaluated under FDA Good Laboratory Practice and ISO systemic-toxicity standards, exceeding the evidentiary depth typically applied in state cannabis oversight and supporting defensible positions during audits, diligence, and incident review.

Tomorrow (federally regulated cannabis): As cannabis transitions into FDA-inspected regulatory frameworks, safety-critical process steps will be expected to carry GLP-grade validation, traceable protocols, and governed records.

This study positions the process within that future inspection model—before it is required.

Full study protocols, raw observations, QA audits, and final reports are maintained under documentation control and are available for compliance or regulatory review subject to confidentiality agreements.

Reactive Oxygen® Environmental Safety — Hydrogen Peroxide Vapor Monitoring

Independent third-party environmental monitoring by SGS Galson (ISO/IEC 17025 accredited)

Independent third-party environmental monitoring of hydrogen peroxide vapor concentration during and after system operation was conducted to validate that vapor levels in areas surrounding the system remain within established occupational exposure limits during normal operation.

Passive air monitoring badges were deployed at multiple operator and facility locations during active system use. Samples were collected under real operating conditions and analyzed using ACS SOP II-99 based on OSHA Method 1019. Exposure was evaluated on an 8-hour time-weighted average basis.

Measured concentrations ranged from less than 0.03 ppm to 0.06 ppm. All recorded values remained well below OSHA's permissible exposure limit of 1.0 ppm based on an 8-hour time-weighted average. No short-term exposure exceedances were observed.

Environmental hydrogen peroxide vapor levels associated with system operation remained orders of magnitude below established occupational exposure limits, confirming controlled containment and exhaust performance under real operating conditions.

—Study type: Independent third-party environmental monitoring
—Laboratory: SGS Galson (ISO/IEC 17025 accredited)
—Analytical support: Advanced Chemical Sensors
—Method: ACS SOP II-99 based on OSHA Method 1019
—Exposure basis: 8-hour time-weighted average
—Measured parameter: Hydrogen peroxide vapor concentration (ppm)
—Sampling locations: Box operator position, inside chamber door, between system units, facility perimeter
—Measured range: <0.03 ppm to 0.06 ppm
—OSHA permissible exposure limit: 1.0 ppm (8-hour TWA)
—Analytical limit of quantitation: 0.03 ppm (8-hour basis)

Role in System Validation

This study documents facility-level environmental control and confirms that purification is achieved without uncontrolled atmospheric release, reinforcing the system as a closed, governed process control infrastructure rather than an ambient treatment method.

Full monitoring reports, sampling data, and laboratory analysis are maintained under documentation control and are available for compliance or regulatory review subject to confidentiality agreements.

TheBOX® Installation & Operational Qualification (IQ/OQ) — Internal Process Validation

Controlled internal validation protocols documenting system installation and operational execution

Installation Qualification (IQ) and Operational Qualification (OQ) were executed under controlled internal validation protocols to document that the system was installed correctly, configured according to specification, and operates consistently within defined parameters under intended operating conditions.

IQ/OQ activities were executed using a predefined protocol (VAL-051-IQ/OQ, Revision 1) and approved acceptance criteria. Verification steps included physical inspection, component verification, utility checks, calibration review, operational testing, and documented cycle execution. All activities were recorded contemporaneously and reviewed against protocol-defined requirements.

Multiple programmed cycles were executed to confirm correct system initialization and sequencing, controlled vacuum, injection, diffusion, and cleaning stages, repeatable timing and pressure profiles, proper alarm handling and cycle completion logic, and accurate generation of cycle records and reports.

The system met all installation and operational qualification requirements. No unresolved deviations were recorded during protocol execution. Validation was completed with a documented PASS outcome.

—Validation type: Installation Qualification (IQ) and Operational Qualification (OQ)
—Validation reference: Protocol VAL-051-IQ/OQ, Revision 1
—Scope — Installation: Equipment installation, configuration verification, utility/power/component conformity, calibration status of critical instruments
—Scope — Operational: Operational sequence execution, cycle parameter consistency and control, documentation/training/procedural compliance
—Operational verification: System initialization, vacuum/injection/diffusion/cleaning stages, timing/pressure profiles, alarm handling, cycle records
—Acceptance criteria: Predefined acceptance criteria specified in IQ/OQ protocol
—Result: PASS — All requirements met, no unresolved deviations

Role in System Validation

This IQ/OQ validation establishes internal process discipline and execution integrity. It confirms that downstream validation, testing, and performance claims are built on a qualified operational foundation rather than assumptions or undocumented setup.

Installation and operational qualification confirmed that the system is installed correctly and operates in accordance with defined specifications and procedural controls, supporting its role as a governed, repeatable process platform.

Full validation protocols, execution records, and deviation logs are maintained under documentation control and are available for compliance or regulatory review subject to confidentiality agreements.

Validation Frameworks

Operator Validation & Audit Documentation

Regulator-aligned documentation structures supporting cannabis operators with audit-ready validation records

TheBOX is supported by regulator-aligned validation frameworks intended to produce audit-ready documentation under state regulatory review. These materials define how purification performance, safety, and material integrity are formally demonstrated, recorded, and reviewed during inspection.

—Framework scope: Purification performance, safety, and material integrity validation
—Documentation purpose: Audit-ready records for state regulatory review
—Operator responsibility: Execution, acceptance, and regulatory submission

Validation Framework (Methodology)

This framework defines the governing structure used to validate purification outcomes within TheBOX system. It establishes standards alignment, acceptance criteria, testing design, and documentation discipline expected in regulated processing environments.

Included within the validation framework:
– Validation objectives covering microbial reduction, safety, and material integrity
– Alignment with recognized standards including USP <61>/<62>, ISO sterilization indicators, European Pharmacopoeia methods, and applicable state microbial limits
– Microbial challenge study structure incorporating representative molds, bacteria, native bioburden, and untreated controls
– Defined process parameters including chamber pressure, exposure duration, sterilant concentration, and environmental conditions
– Use of chemical and biological indicators to verify cycle performance and load penetration
– Physicochemical and organoleptic assessment criteria addressing cannabinoids, terpenes, moisture equilibrium, and sensory attributes
– Shelf-life and stability study structure under real-time and accelerated storage conditions
– GMP-aligned documentation, traceability, deviation handling, and data retention expectations
– Environmental and occupational safety monitoring tied to established exposure limits

This framework establishes how validation is structured, not how equipment is operated.

Validation Summary Report (Audit Record)

The validation summary report provides a standardized, regulator-facing record used to document execution and outcomes of a facility-specific validation.

The report structure captures:
– Facility, equipment, and sterilant identification
– Defined test conditions and verified process parameters
– Microbial reduction results and acceptance determinations
– Shelf-life and stability data over defined intervals
– Cannabinoid, terpene, moisture, and sensory comparisons against untreated controls
– Environmental safety monitoring results
– Deviations, corrective actions, and final acceptance statements
– Review, approval, and accountability signatures

Execution, acceptance, and regulatory submission remain the responsibility of the operator. Validation frameworks provide documentation structure consistent with regulator expectations in controlled processing environments.

Documentation Governance

Validation protocols, test results, and process documentation are maintained and governed. Documentation includes biological indicator validation records, internal field testing data, and process parameter specifications.

Access to validation documentation requires executed non-disclosure agreements or confidentiality provisions. Documentation is provided only to qualified requests from licensed operators, compliance professionals, or regulatory bodies with legitimate review purposes.

Qualified documentation requests are processed in the order received. Response times vary based on documentation type, requestor credentials, and access requirements.

Documentation Notice

This page is provided for informational purposes only and does not constitute a binding offer, guarantee of performance, or warranty of outcomes.

Validation documentation referenced herein is subject to access requirements and may require executed agreements prior to release. Documentation availability and content are subject to change.

Regulatory classifications and standards referenced are accurate as of publication. Regulatory status may change. Consult current regulatory guidance for compliance determinations.

References

ISO 22441:2022 — Sterilization of health care products — Low temperature vaporized hydrogen peroxide — Requirements for the development, validation and routine control of a sterilization process for medical devices

ISO 14937:2009 — Sterilization of health care products — General requirements for characterization of a sterilizing agent and the development, validation and routine control of a sterilization process for medical devices

FDA 21 CFR Part 58 — Good Laboratory Practice for Nonclinical Laboratory Studies — Federal requirements governing the conduct and reporting of nonclinical safety studies

ICH Q7 — Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients — International harmonized guidance on GMP requirements for pharmaceutical manufacturing

USP General Chapters — United States Pharmacopeia standards for microbial enumeration (<61>), specified microorganisms (<62>), and cannabis quality (draft chapter <1568>)

Content last reviewed April 2026 by BoxPurify technical team

For documentation access requests, compliance inquiries, or NDA coordination, contact your PuroGen representative.